Form D Explorer
Renasant Bio, Inc. · CIK 2075979

Report a data issueCitable research briefCompare issuerPrivate research collection

Renasant Bio, Inc.

CIK 2075979 · Corporation · Inc. DELAWARE · BERKELEY, California · Biotechnology
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
Jul 14, 2025
through Jul 14, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Both filings have the same date. Their sequence is unknown; directional differences are suppressed.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 14, 2025 · DJul 14, 2025 · DLater minus earlier
Reported offering amount$25,461,184$30,000,000—
Reported amount sold$25,461,184$30,000,000—
Reported investor count———
Reported minimum investment$0$0—

Earlier SEC source: 0001231919-25-000108 · Later SEC source: 0001231919-25-000109

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Jul 14, 2025

Reported offering amount
$30,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$30,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)